Nanotechnology Now

• About Us
  
  • Advertising
  • Our Mission
  • Our Team
  • Comments
  • Friends
  • Contact
• Nanotechnology
• News
  
  • Current News
  • Press Releases
  • Submit Press
  • Press kit
  • Interviews
• Columns
• Products
  
  • Our Products
  • Books
  • Featured Books
• Directories
  
  • Companies/Academic
  • Events
  • Glossary
  • Best Of
• Career Center
• Nano-Social Network
• Nano Consulting
• My Account

Home > News > Stock Report Coverage on BioSante Pharmaceuticals

September 25th, 2006

Stock Report Coverage on BioSante Pharmaceuticals

Abstract:
Standard & Poor’s announced today that it has commenced Factual Stock Report coverage on BioSante Pharmaceuticals, Inc. ... (AMEX:BPA) is a development stage biopharmaceutical company that is developing a pipeline of hormone therapy products to treat men and women.

Source:
businesswire

Bookmark:

Related Links

BioSante Pharmaceuticals

Related News Press

Investments/IPO's/Splits

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

Harris & Harris Group Notes the Sale of a Second D-Wave Quantum Computer May 16th, 2013

Nanometrics Announces Upcoming Investor Events May 14th, 2013

Nanostart-holding New Asia Investments invests in breakthrough water projects May 13th, 2013

Announcements

Aspen Aerogels Announces $22.5 Million Private Placement May 18th, 2013

NanoInk, Inc. Assets To Be Sold May 18th, 2013

NIA Public Briefing: Nanotechnology and the Council of Europe May 17th, 2013

Scientists capture first direct proof of Hofstadter butterfly effect May 17th, 2013

Financial Reports

Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013

Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013

Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013

Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013